cysteine has been researched along with Angiogenesis, Pathologic in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (6.45) | 18.2507 |
| 2000's | 10 (32.26) | 29.6817 |
| 2010's | 15 (48.39) | 24.3611 |
| 2020's | 4 (12.90) | 2.80 |
| Authors | Studies |
|---|---|
| Akaike, T; Balog, N; Børresen Dale, AL; Csuka, O; Czikora, Á; Ditrói, T; Engebraten, O; Erdélyi, K; Hajdú, D; Ida, T; Johansson, HJ; Kásler, M; Lehtiö, J; Mátrai, Z; Nagy, P; Olasz, J; Silwal-Pandit, L; Tóvári, J; Uchida, K | 1 |
| Chen, S; Fu, Y; Guan, Z; Jiang, Y; Luo, L; Qian, T; Sun, X; Tang, M; Wu, J; Zheng, Z | 1 |
| Deng, SK; Jin, Y; Wang, JF | 1 |
| Ascenção, K; Lheimeur, B; Szabo, C | 1 |
| Baral, R; Basu, A; Bhattacharjee, A; Bhattacharya, S; Biswas, J; Samanta, A | 1 |
| Basu, A; Bhattacharjee, A; Bhattacharya, S; Ghosh, P; Samanta, A | 1 |
| Chen, R; Li, XZ; Sohawon, Y; Tong, MQ; Wang, LF; Xiao, J; Xu, HL; Yao, Q; Zhao, YZ | 1 |
| Bakakos, P; Hillas, G; Kostikas, K; Koulouris, NG; Loukides, S; Papadaki, G; Papiris, S; Tsilogianni, Z | 1 |
| Bao, G; Guo, W; Huang, C; Kan, J; Zhu, Y; Zhu, YZ | 1 |
| Abdul-Wahid, A; Bourdeau, A; Bowden, K; Brown, TJ; Cydzik, M; Gariépy, J; Kollara, A; Park, S; Prodeus, A; Ringuette, MJ | 1 |
| Bachschmid, MM; Behring, JB; Bolotina, VM; Cohen, RA; Evangelista, AM; Haeussler, DJ; Han, J; Matsui, R; Mei, Y; Murdoch, CE; Smith, MD; Tong, X; Watanabe, Y | 1 |
| Butler, CT; Cagney, G; Dillon, ET; Guiry, PJ; Kennedy, BN; O'Sullivan, J; Reynolds, AL; Tosetto, M | 1 |
| Bhattacharya, A; Oven, SD; Rustum, YM; Seshadri, M; Tóth, K; Vaughan, MM | 1 |
| Belame, A; Burow, ME; Carrier, L; Li, Z; Rowan, BG; Salvo, VA; Thiyagarajah, A | 1 |
| Bhattacharya, A; Cao, S; Durrani, FA; Faber, E; Repasky, EA; Rustum, YM; Sen, A; Seshadri, M; Tóth, K | 1 |
| Feng, J; Lu, D; Qiu, Y; Yan, X; Yang, D; Zeng, Q; Zhang, Y; Zheng, C | 1 |
| Backer, JM; Backer, M; Eder, M; Eisenhut, M; Haberkorn, U; Krivoshein, AV | 1 |
| Bhattacharya, A; Hoffman, RM; Rajput, A; Rustum, YM; San Martin, ID; Seshadri, M; Turowski, SG | 1 |
| Bernhard, EJ | 1 |
| Aggarwal, BB; Gupta, SC; Phatak, SS; Prasad, S; Sung, B; Yadav, VR; Zhang, S | 1 |
| Choi, C; Kang, DH; Kang, SW; Kim, J; Koh, GY; Koh, YJ; Lee, DJ; Lee, JY; Lee, KW; Lee, SH; Park, YS; Yu, DY | 1 |
| Evan, G; Hanahan, D; Nozawa, H; Rostker, F; Shchors, K; Swigart-Brown, L; Xu, J | 1 |
| Aimoto, S; Hiraki, Y; Kawakami, T; Kondo, J; Miura, S; Shukunami, C; Tanaka, H | 1 |
| Chorostowska-Wynimko, J; Jankun, J; Selman, SH; Skrzypczak-Jankun, E; Swiercz, R; Wojtowicz, A | 1 |
| Boykins, RA; Clouse, KA; Devadas, K; Dhawan, S; Hardegen, NJ; Hewlett, IK; Kleinman, HK; Osa, EO; Philp, D; Rappaport, J; Wahl, LM; Wang, J; Yamada, KM | 1 |
| Azrak, RG; Bhattacharya, A; Cao, S; Durrani, FA; Frank, C; Hapke, G; Li, ZR; Rustum, YM; Tóth, K; Yin, MB | 1 |
| Clark, CJ; Sage, EH | 1 |
| Backer, JM; Backer, M; Blankenberg, FG; Levashova, Z | 1 |
| Chang, YH; Griffith, EC; Liu, JO; Niwayama, S; Ramsay, CA; Su, Z | 1 |
| Higuchi, T; Ilgan, S; Kim, EE; Liu, CW; Oh, CS; Podoloff, DA; Yang, DJ; Zareneyrizi, F | 1 |
| Abbruzzes, J; Azhdarinia, A; Bryant, JL; Fogler, WE; Herbst, R; Kalimi, SK; Kim, EE; Kim, KD; Ozaki, K; Podoloff, DA; Roach, JS; Schechter, NR; Wu, P; Yang, DJ; Yu, DF | 1 |
3 review(s) available for cysteine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Endothelial Cell Redox Regulation of Ischemic Angiogenesis.
Topics: Animals; Cysteine; Endothelial Cells; Glutaredoxins; Glutathione; Humans; Ischemia; Neovascularization, Pathologic; NF-kappa B; Oxidation-Reduction; Reactive Oxygen Species; Sarcoplasmic Reticulum Calcium-Transporting ATPases | 2016 |
Interventions that induce modifications in the tumor microenvironment.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antineoplastic Agents; Cell Adhesion; Cell Hypoxia; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Cysteine; Cytotoxins; Drug Screening Assays, Antitumor; Extracellular Matrix; Genetic Therapy; Humans; Immunotherapy; Molecular Targeted Therapy; Neoplasm Proteins; Neoplasms; Neoplasms, Experimental; Neoplastic Stem Cells; Neovascularization, Pathologic; Organoselenium Compounds; Radiation Tolerance; Radiotherapy; Selenocysteine; Signal Transduction; Stromal Cells; Tumor Microenvironment | 2011 |
A prototypic matricellular protein in the tumor microenvironment--where there's SPARC, there's fire.
Topics: Animals; Biological Evolution; Cell Movement; Computational Biology; Cysteine; Disease Progression; Glycoproteins; Humans; Models, Biological; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic; Osteonectin; Systems Biology | 2008 |
28 other study(ies) available for cysteine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Reprogrammed transsulfuration promotes basal-like breast tumor progression via realigning cellular cysteine persulfidation.
Topics: Animals; Cohort Studies; Cystathionine beta-Synthase; Cysteine; Disease Progression; Female; Ferroptosis; Humans; Mice, SCID; Neovascularization, Pathologic; Oxidative Stress; Sulfides; Triple Negative Breast Neoplasms | 2021 |
Secreted Protein Acidic and Rich in Cysteine Mediates the Development and Progression of Diabetic Retinopathy.
Topics: Cysteine; Diabetes Mellitus; Diabetic Retinopathy; Endothelial Cells; Humans; Integrin beta1; Neovascularization, Pathologic; Osteonectin; Proteins | 2022 |
SPARC induces M2 polarization of macrophages to promote proliferation, migration, and angiogenesis of cholangiocarcinoma cells.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cell Proliferation; Cholangiocarcinoma; Cysteine; Humans; Macrophages; Neovascularization, Pathologic; Osteonectin; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt | 2022 |
Regulation of CyR61 expression and release by 3-mercaptopyruvate sulfurtransferase in colon cancer cells.
Topics: Aminooxyacetic Acid; Antineoplastic Agents; Colonic Neoplasms; Cystathionine; Cystathionine beta-Synthase; Cysteine; Cysteine-Rich Protein 61; Humans; Hydrogen Sulfide; Neovascularization, Pathologic; RNA, Messenger; Sulfurtransferases | 2022 |
Vanadium(III)-l-cysteine enhances the sensitivity of murine breast adenocarcinoma cells to cyclophosphamide by promoting apoptosis and blocking angiogenesis.
Topics: Adenocarcinoma; Animals; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Coordination Complexes; Cyclophosphamide; Cysteine; Disease Models, Animal; DNA Damage; Drug Resistance, Neoplasm; Female; Humans; Mammary Neoplasms, Animal; Mice; Neovascularization, Pathologic; Oxidative Stress; Reactive Oxygen Species | 2017 |
Sensitizing effects of an organovanadium compound during adjuvant therapy with cyclophosphamide in a murine tumor model.
Topics: Animals; Antineoplastic Agents; Antioxidants; Apoptosis; Apoptosis Regulatory Proteins; Cell Line, Tumor; Chemotherapy, Adjuvant; Cyclophosphamide; Cysteine; DNA Damage; Down-Regulation; Female; Mice; Neoplasms; Neovascularization, Pathologic; Oxidative Stress; Reactive Oxygen Species; Signal Transduction; Up-Regulation; Vanadium Compounds | 2017 |
Thiolated γ-polyglutamic acid as a bioadhesive hydrogel-forming material: evaluation of gelation, bioadhesive properties and sustained release of KGF in the repair of injured corneas.
Topics: Adhesiveness; Animals; Apoptosis; Cell Proliferation; Corneal Injuries; Cysteine; Delayed-Action Preparations; Drug Carriers; Fibroblast Growth Factor 7; Fibrosis; Hydrogels; Mice; Neovascularization, Pathologic; NIH 3T3 Cells; Polyglutamic Acid | 2019 |
Vascular endothelial growth factor and cysteinyl leukotrienes in sputum supernatant of patients with asthma.
Topics: Adult; Analysis of Variance; Asthma; Capillary Permeability; Case-Control Studies; Cysteine; Female; Forced Expiratory Volume; Humans; Hypersensitivity; Leukotrienes; Male; Middle Aged; Neovascularization, Pathologic; Smoking; Sputum; Up-Regulation; Vascular Endothelial Growth Factor A; Vital Capacity | 2013 |
S-propargyl-cysteine, a novel water-soluble modulator of endogenous hydrogen sulfide, promotes angiogenesis through activation of signal transducer and activator of transcription 3.
Topics: Active Transport, Cell Nucleus; Angiogenesis Inducing Agents; Animals; Cell Adhesion; Cell Movement; Cell Proliferation; Cysteine; Disease Models, Animal; Human Umbilical Vein Endothelial Cells; Humans; Hydrogen Sulfide; Male; Mice; Myocardial Ischemia; Neovascularization, Pathologic; Neovascularization, Physiologic; Protein Binding; Protein Transport; Rats; STAT3 Transcription Factor; Transcriptional Activation; Vascular Endothelial Growth Factor Receptor-2 | 2014 |
Slow binding kinetics of secreted protein, acidic, rich in cysteine-VEGF interaction limit VEGF activation of VEGF receptor 2 and attenuate angiogenesis.
Topics: Cell Line; Cell Movement; Cell Proliferation; Cysteine; Endothelial Cells; Human Umbilical Vein Endothelial Cells; Humans; Kinetics; MAP Kinase Signaling System; Neovascularization, Pathologic; Osteonectin; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Binding; Proto-Oncogene Proteins c-akt; Receptors, Vascular Endothelial Growth Factor; Signal Transduction; Vascular Endothelial Growth Factor A | 2015 |
A Quininib Analogue and Cysteinyl Leukotriene Receptor Antagonist Inhibits Vascular Endothelial Growth Factor (VEGF)-independent Angiogenesis and Exerts an Additive Antiangiogenic Response with Bevacizumab.
Topics: Angiogenesis Inhibitors; Animals; Animals, Genetically Modified; Benzene Derivatives; Bevacizumab; Cell Line; Cell Movement; Cell Survival; Cysteine; Dose-Response Relationship, Drug; Endothelial Cells; Green Fluorescent Proteins; Humans; Leukotriene Antagonists; Microscopy, Fluorescence; Neovascularization, Pathologic; Phenols; Quinolines; Recombinant Proteins; Signal Transduction; Vascular Endothelial Growth Factor A; Zebrafish | 2017 |
Tumor vascular maturation and improved drug delivery induced by methylselenocysteine leads to therapeutic synergy with anticancer drugs.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Capillary Permeability; Carcinoma, Squamous Cell; Cysteine; Drug Delivery Systems; Drug Synergism; Female; Head and Neck Neoplasms; Humans; Mice; Mice, Nude; Neovascularization, Pathologic; Organoselenium Compounds; Selenocysteine; Xenograft Model Antitumor Assays | 2008 |
Combination of methylselenocysteine with tamoxifen inhibits MCF-7 breast cancer xenografts in nude mice through elevated apoptosis and reduced angiogenesis.
Topics: Adenocarcinoma; Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Cell Division; Cyclin D1; Cysteine; Drug Synergism; Estradiol; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Neovascularization, Pathologic; Organoselenium Compounds; Random Allocation; Receptors, Progesterone; Selenocysteine; Specific Pathogen-Free Organisms; Tamoxifen; Xenograft Model Antitumor Assays | 2009 |
Inhibition of colon cancer growth by methylselenocysteine-induced angiogenic chemomodulation is influenced by histologic characteristics of the tumor.
Topics: Animals; Antibiotics, Antineoplastic; Anticarcinogenic Agents; Cell Differentiation; Colon; Colorectal Neoplasms; Cysteine; Doxorubicin; Drug Delivery Systems; Drug Resistance, Neoplasm; Female; Humans; Hypoxia; Immunoenzyme Techniques; Magnetic Resonance Imaging; Mice; Mice, Nude; Neovascularization, Pathologic; Organoselenium Compounds; Selenocysteine; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2009 |
Endothelial CD146 is required for in vitro tumor-induced angiogenesis: the role of a disulfide bond in signaling and dimerization.
Topics: Angiogenesis Inducing Agents; Animals; Antibodies, Monoclonal; CD146 Antigen; Cell Line, Tumor; Culture Media, Conditioned; Cysteine; Disulfides; Endothelial Cells; Epitope Mapping; Epitopes; Humans; I-kappa B Kinase; Morphogenesis; Neoplasms; Neovascularization, Pathologic; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Protein Multimerization; Signal Transduction; Structure-Activity Relationship; Up-Regulation | 2009 |
ScVEGF-PEG-HBED-CC and scVEGF-PEG-NOTA conjugates: comparison of easy-to-label recombinant proteins for [68Ga]PET imaging of VEGF receptors in angiogenic vasculature.
Topics: Acetates; Animals; Cell Line, Tumor; Chelating Agents; Cysteine; Ethylenediamines; Gallium Radioisotopes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Isotope Labeling; Mice; Neovascularization, Pathologic; Polyethylene Glycols; Positron-Emission Tomography; Receptors, Vascular Endothelial Growth Factor; Recombinant Proteins; Vascular Endothelial Growth Factor A | 2010 |
Magnetic resonance and fluorescence-protein imaging of the anti-angiogenic and anti-tumor efficacy of selenium in an orthotopic model of human colon cancer.
Topics: Adenocarcinoma; Animals; Colonic Neoplasms; Cysteine; Diagnostic Imaging; Female; Green Fluorescent Proteins; Humans; Magnetic Resonance Imaging; Mice; Mice, Nude; Microvessels; Neovascularization, Pathologic; Organoselenium Compounds; Random Allocation; Selenocysteine; Xenograft Model Antitumor Assays | 2011 |
3-Formylchromone interacts with cysteine 38 in p65 protein and with cysteine 179 in IκBα kinase, leading to down-regulation of nuclear factor-κB (NF-κB)-regulated gene products and sensitization of tumor cells.
Topics: Active Transport, Cell Nucleus; Antineoplastic Agents; Apoptosis; Carcinogens; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Survival; Chromones; Cyclooxygenase 2; Cysteine; DNA; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Activation; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; I-kappa B Kinase; MAP Kinase Kinase Kinases; Models, Molecular; Neoplasm Invasiveness; Neovascularization, Pathologic; Phosphorylation; Promoter Regions, Genetic; Protein Binding; Protein Conformation; Proteolysis; Time Factors; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2012 |
Peroxiredoxin II is an essential antioxidant enzyme that prevents the oxidative inactivation of VEGF receptor-2 in vascular endothelial cells.
Topics: Animals; Antioxidants; Aorta; Carcinoma, Lewis Lung; Caveolae; Cysteine; Disulfides; Endothelial Cells; Endothelium, Vascular; Gene Silencing; Humans; Hydrogen Peroxide; Mice; Mice, Knockout; Mutagenesis, Site-Directed; Neoplasm Transplantation; Neovascularization, Pathologic; Oxidation-Reduction; Peroxiredoxins; Protein Binding; Protein Structure, Tertiary; Reactive Oxygen Species; RNA, Small Interfering; Signal Transduction; Vascular Endothelial Growth Factor Receptor-2 | 2011 |
Increased invasiveness of MMP-9-deficient tumors in two mouse models of neuroendocrine tumorigenesis.
Topics: Animals; bcl-X Protein; Cathepsin B; CD11b Antigen; Cell Transformation, Neoplastic; Cysteine; Disease Models, Animal; GTPase-Activating Proteins; Inflammation; Interleukin-1beta; Leukocytes; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred C57BL; Neoplasm Invasiveness; Neovascularization, Pathologic; Neuroendocrine Tumors; Pancreatic Neoplasms; Proto-Oncogene Proteins c-myc | 2013 |
Synthetic disulfide-bridged cyclic peptides mimic the anti-angiogenic actions of chondromodulin-I.
Topics: Amino Acid Sequence; Angiogenesis Inhibitors; Animals; Cattle; Cell Line, Tumor; Cell Movement; Cells, Cultured; Chondrosarcoma; Cysteine; Disulfides; Dose-Response Relationship, Drug; Human Umbilical Vein Endothelial Cells; Humans; Intercellular Signaling Peptides and Proteins; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Sequence Data; Mutagenesis, Site-Directed; Mutation; Neovascularization, Pathologic; Peptides, Cyclic; Recombinant Proteins; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2012 |
A novel form of the plasminogen activator inhibitor created by cysteine mutations extends its half-life: relevance to cancer and angiogenesis.
Topics: Amino Acid Sequence; Amino Acid Substitution; Base Sequence; Binding Sites; Cysteine; DNA Primers; Endothelium, Vascular; Half-Life; Humans; Kinetics; Models, Molecular; Mutagenesis, Site-Directed; Neoplasms; Neovascularization, Pathologic; Plasminogen Activator Inhibitor 1; Polymerase Chain Reaction; Protein Conformation; Protein Structure, Secondary; Recombinant Proteins; Sequence Alignment; Sequence Homology, Amino Acid; Urokinase-Type Plasminogen Activator | 2003 |
Selective side-chain modification of cysteine and arginine residues blocks pathogenic activity of HIV-1-Tat functional peptides.
Topics: Arginine; Cell Line; Cell Line, Tumor; Cysteine; DNA Replication; Enzyme Activation; Gene Products, tat; HIV Infections; HIV-1; Humans; Molecular Structure; Neovascularization, Pathologic; NF-kappa B; Peptide Fragments; Receptors, CCR5; Recombinant Proteins; tat Gene Products, Human Immunodeficiency Virus | 2006 |
Potentiation of irinotecan sensitivity by Se-methylselenocysteine in an in vivo tumor model is associated with downregulation of cyclooxygenase-2, inducible nitric oxide synthase, and hypoxia-inducible factor 1alpha expression, resulting in reduced angiog
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Camptothecin; Carcinoma, Squamous Cell; Cyclooxygenase 2; Cysteine; Down-Regulation; Female; Head and Neck Neoplasms; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Irinotecan; Mice; Mice, Nude; Neovascularization, Pathologic; Nitric Oxide Synthase Type II; Organoselenium Compounds; Selenocysteine; Transplantation, Heterologous | 2006 |
Direct site-specific labeling of the Cys-tag moiety in scVEGF with technetium 99m.
Topics: Animals; Binding Sites; Cysteine; Disease Models, Animal; Female; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Neovascularization, Pathologic; Organ Specificity; Radionuclide Imaging; Radiopharmaceuticals; Staining and Labeling; Technetium; Tissue Distribution; Vascular Endothelial Growth Factor A | 2008 |
Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2.
Topics: Amino Acid Sequence; Aminopeptidases; Animals; Anti-Bacterial Agents; Catalytic Domain; Cell Division; Cell Line; Cyclohexanes; Cysteine; Endothelium, Vascular; Fatty Acids, Unsaturated; Histidine; Humans; Metalloendopeptidases; Mutagenesis, Site-Directed; Neovascularization, Pathologic; Recombinant Proteins; Sesquiterpenes; Spodoptera; Transfection | 1998 |
Noninvasive assessment of tumor hypoxia with 99mTc labeled metronidazole.
Topics: Animals; Autoradiography; Cell Hypoxia; Cysteine; Female; Fluorine Radioisotopes; Iodine Radioisotopes; Mammary Neoplasms, Experimental; Metronidazole; Microelectrodes; Misonidazole; Neovascularization, Pathologic; Organotechnetium Compounds; Oxygen; Radiation-Sensitizing Agents; Radionuclide Imaging; Rats; Rats, Inbred F344; Tissue Distribution | 1999 |
Assessment of antiangiogenic effect using 99mTc-EC-endostatin.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Collagen; Cysteine; Endostatins; Endothelial Growth Factors; Female; Fibroblast Growth Factor 2; In Situ Nick-End Labeling; Intercellular Signaling Peptides and Proteins; Interleukin-8; Lymphokines; Mammary Neoplasms, Experimental; Neovascularization, Pathologic; Paclitaxel; Peptide Fragments; Radionuclide Imaging; Rats; Rats, Inbred F344; Technetium; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2002 |